These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27554129)

  • 1. Editorial (Thematic Issue: Development of Biomarkers in Tumors of Digestive System Part II).
    Zhi Q
    Anticancer Agents Med Chem; 2016; 16(9):1078. PubMed ID: 27554129
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial: Special Thematic Issuue: Development of Biomarkers in Tumors of Digestive System Part I.
    Zhi Q
    Anticancer Agents Med Chem; 2016; 16(4):406. PubMed ID: 26961482
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of Non-Coding RNAs as Biomarkers in Tumors of Digestive System.
    Xu Z; Zhi Q
    Anticancer Agents Med Chem; 2019; 19(2):143-144. PubMed ID: 31298143
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic value of long non-coding RNA UCA1 in digestive system malignancies.
    Song N; Zhai H; Li XM; Chen QJ; Huang GN; Liu F; Yang YN
    Minerva Med; 2017 Aug; 108(4):386-387. PubMed ID: 28677365
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnosis of digestive tract cancer using cDNA probe and monoclonal antibody.
    Imai K
    Jpn J Med; 1990; 29(6):659-61. PubMed ID: 2101420
    [No Abstract]   [Full Text] [Related]  

  • 6. Biochemical and immunologic diagnosis of cancer. Consensus report, 1987.
    Tumour Biol; 1987; 8(2-3):65-74. PubMed ID: 3448766
    [No Abstract]   [Full Text] [Related]  

  • 7. NCCN Clinical Practice Guidelines in Oncology: neuroendocrine tumors.
    Clark OH; Benson AB; Berlin JD; Choti MA; Doherty GM; Engstrom PF; Gibbs JF; Heslin MJ; Kessinger A; Kulke MH; Kvols L; Salem R; Saltz L; Shah MH; Shibata S; Strosberg JR; Yao JC;
    J Natl Compr Canc Netw; 2009 Jul; 7(7):712-47. PubMed ID: 19635226
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical value of octamer-binding transcription factor 4 as a prognostic marker in patients with digestive system cancers: A systematic review and meta-analysis.
    Chen Z; Zhang L; Zhu Q; Wang X; Wu J; Wang X
    J Gastroenterol Hepatol; 2017 Mar; 32(3):567-576. PubMed ID: 28320060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-139 in digestive system tumor diagnosis and detection: Bioinformatics and meta-analysis.
    Wang YH; Ji J; Weng H; Wang BC; Wang FB
    Clin Chim Acta; 2018 Oct; 485():33-41. PubMed ID: 29883634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCA1 and BRCA2 expression patterns and prognostic significance in digestive system cancers.
    Wang GH; Zhao CM; Huang Y; Wang W; Zhang S; Wang X
    Hum Pathol; 2018 Jan; 71():135-144. PubMed ID: 29126833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal tissue-based molecular biomarkers: a practical categorisation based on the 2019 World Health Organization classification of epithelial digestive tumours.
    Quezada-Marín JI; Lam AK; Ochiai A; Odze RD; Washington KM; Fukayama M; Rugge M; Klimstra DS; Nagtegaal ID; Tan PH; Arends MJ; Goldblum JR; Cree IA; Salto-Tellez M
    Histopathology; 2020 Sep; 77(3):340-350. PubMed ID: 32320495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transcription factors: which diagnostic applications?].
    Scoazec JY
    Ann Pathol; 2012 Nov; 32(5 Suppl):S32-3. PubMed ID: 23127931
    [No Abstract]   [Full Text] [Related]  

  • 13. DNA methylation markers in patients with gastrointestinal cancers. Current understanding, potential applications for disease management and development of diagnostic tools.
    Lofton-Day C; Lesche R
    Dig Dis; 2003; 21(4):299-308. PubMed ID: 14752219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biomarkers for neoplasmas in digestive organs].
    Iwasaki Y; Arai K; Katayanagi S; Takahashi K; Yamaguchi T; Matsumoto H; Miyamoto H
    Gan To Kagaku Ryoho; 2004 Jul; 31(7):1015-20. PubMed ID: 15272578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical studies on the localization of cancer associated antigens DU-PAN-2 and CA19-9 in carcinomas of the digestive tract.
    Ohshio G; Ogawa K; Kudo H; Yamabe H; Nakashima Y; Kim YC; Endo K; Watanabe Y; Manabe T; Tobe T
    J Gastroenterol Hepatol; 1990; 5(1):25-31. PubMed ID: 2103381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA XIST predicts worse prognosis in digestive system tumors: a systemic review and meta-analysis.
    Liu X; Ming X; Jing W; Luo P; Li N; Zhu M; Yu M; Liang C; Tu J
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29752340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44 as a marker in human cancers.
    Sy MS; Mori H; Liu D
    Curr Opin Oncol; 1997 Jan; 9(1):108-12. PubMed ID: 9090502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [History of tumor markers for cancers of the digestive system].
    Buzás GM
    Orv Hetil; 2013 May; 154(21):810-9. PubMed ID: 23692875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practical Immunohistochemistry in Neoplastic Pathology of the Gastrointestinal Tract, Liver, Biliary Tract, and Pancreas.
    Wang HL; Kim CJ; Koo J; Zhou W; Choi EK; Arcega R; Chen ZE; Wang H; Zhang L; Lin F
    Arch Pathol Lab Med; 2017 Sep; 141(9):1155-1180. PubMed ID: 28854347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum level of tumor markers (antigen Ca 19-9, CEA, ferritin) in digestive tumors. Their diagnostic usefulness].
    Jovin G; Stănel I; Popovici I; Oproiu A
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(3):223-9. PubMed ID: 2904162
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.